APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canine Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Canine Influenza Vaccine Market Analysis and Forecast 2026-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchCanine Influenza Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Influenza Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Canine Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Influenza Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Influenza Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Canine Influenza Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Canine Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Canine Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Canine Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Canine Influenza Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Canine Influenza Vaccine include Bharat Biotech, CNBG, CSL Limited, LIAONING CHENGDA, Merck Animal Health, GSK, Roche, Novartis and Zoetis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Canine Influenza Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Canine Influenza Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Canine Influenza Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Canine Influenza Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Canine Influenza Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Canine Influenza Vaccine sales, projected growth trends, production technology, application and end-user industry.

Canine Influenza Vaccine Segment by Company

Bharat Biotech

CNBG

CSL Limited

LIAONING CHENGDA

Merck Animal Health

GSK

Roche

Novartis

Zoetis

Canine Influenza Vaccine Segment by Type

H3N2 Vaccine

H3N8 Vaccine

Canine Influenza Vaccine Segment by Application

Vaccination Clinic

Pet Hospital

Others

Canine Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Canine Influenza Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Canine Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Canine Influenza Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Canine Influenza Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. H3N2 Vaccine Major Manufacturers Table 3. H3N8 Vaccine Major Manufacturers Table 4. Global Canine Influenza Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Vaccination Clinic Major Manufacturers Table 6. Pet Hospital Major Manufacturers Table 7. Others Major Manufacturers Table 8. Canine Influenza Vaccine Industry Trends Table 9. Canine Influenza Vaccine Industry Drivers Table 10. Canine Influenza Vaccine Industry Opportunities and Challenges Table 11. Canine Influenza Vaccine Industry Restraints Table 12. Global Canine Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Canine Influenza Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Canine Influenza Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Canine Influenza Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Canine Influenza Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Canine Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Canine Influenza Vaccine Sales by Region (2021-2026) & (W Units) Table 19. Global Canine Influenza Vaccine Sales by Region (2027-2032) & (W Units) Table 20. Global Canine Influenza Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Canine Influenza Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Canine Influenza Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Canine Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Canine Influenza Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Canine Influenza Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Canine Influenza Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Canine Influenza Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Canine Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Canine Influenza Vaccine Manufacturers, Product Type & Application Table 30. Global Canine Influenza Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Canine Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Canine Influenza Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Canine Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Canine Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Canine Influenza Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Canine Influenza Vaccine Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 40. Global Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 41. Global Canine Influenza Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Canine Influenza Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Canine Influenza Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Canine Influenza Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Canine Influenza Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Canine Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Canine Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Canine Influenza Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Canine Influenza Vaccine Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 52. Global Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 53. Global Canine Influenza Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Canine Influenza Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Canine Influenza Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Canine Influenza Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. Bharat Biotech Company Information Table 58. Bharat Biotech Business Overview Table 59. Bharat Biotech Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bharat Biotech Canine Influenza Vaccine Product Portfolio Table 61. Bharat Biotech Recent Development Table 62. CNBG Company Information Table 63. CNBG Business Overview Table 64. CNBG Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. CNBG Canine Influenza Vaccine Product Portfolio Table 66. CNBG Recent Development Table 67. CSL Limited Company Information Table 68. CSL Limited Business Overview Table 69. CSL Limited Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. CSL Limited Canine Influenza Vaccine Product Portfolio Table 71. CSL Limited Recent Development Table 72. LIAONING CHENGDA Company Information Table 73. LIAONING CHENGDA Business Overview Table 74. LIAONING CHENGDA Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio Table 76. LIAONING CHENGDA Recent Development Table 77. Merck Animal Health Company Information Table 78. Merck Animal Health Business Overview Table 79. Merck Animal Health Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Animal Health Canine Influenza Vaccine Product Portfolio Table 81. Merck Animal Health Recent Development Table 82. GSK Company Information Table 83. GSK Business Overview Table 84. GSK Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GSK Canine Influenza Vaccine Product Portfolio Table 86. GSK Recent Development Table 87. Roche Company Information Table 88. Roche Business Overview Table 89. Roche Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Roche Canine Influenza Vaccine Product Portfolio Table 91. Roche Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novartis Canine Influenza Vaccine Product Portfolio Table 96. Novartis Recent Development Table 97. Zoetis Company Information Table 98. Zoetis Business Overview Table 99. Zoetis Canine Influenza Vaccine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Zoetis Canine Influenza Vaccine Product Portfolio Table 101. Zoetis Recent Development Table 102. North America Canine Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Canine Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 105. North America Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 106. North America Canine Influenza Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Canine Influenza Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Canine Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Canine Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 111. North America Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 112. North America Canine Influenza Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Canine Influenza Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Canine Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Canine Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 118. North America Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 119. North America Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 120. North America Canine Influenza Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Canine Influenza Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Canada Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Europe Canine Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Canine Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 127. Europe Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 128. Europe Canine Influenza Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 129. Europe Canine Influenza Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 130. Europe Canine Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Canine Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 133. Europe Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 134. Europe Canine Influenza Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 135. Europe Canine Influenza Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Europe Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Canine Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Canine Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 140. Europe Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 141. Europe Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 142. Europe Canine Influenza Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 143. Europe Canine Influenza Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 144. Germany Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 145. France Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 146. U.K. Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Italy Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 149. China Canine Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 150. China Canine Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 151. China Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 152. China Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 153. China Canine Influenza Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 154. China Canine Influenza Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 155. China Canine Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 156. China Canine Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 157. China Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 158. China Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 159. China Canine Influenza Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 160. China Canine Influenza Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Canine Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Canine Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 164. Asia Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 165. Asia Canine Influenza Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Asia Canine Influenza Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Asia Canine Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Canine Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 170. Asia Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 171. Asia Canine Influenza Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Asia Canine Influenza Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Asia Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Canine Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Canine Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 177. Asia Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 178. Asia Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 179. Asia Canine Influenza Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Asia Canine Influenza Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Japan Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 182. South Korea Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 183. India Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Australia Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 185. China Taiwan Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Canine Influenza Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Canine Influenza Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Canine Influenza Vaccine Sales by Type (2021-2026) & (W Units) Table 190. SAMEA Canine Influenza Vaccine Sales by Type (2027-2032) & (W Units) Table 191. SAMEA Canine Influenza Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 192. SAMEA Canine Influenza Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 193. SAMEA Canine Influenza Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Canine Influenza Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Canine Influenza Vaccine Sales by Application (2021-2026) & (W Units) Table 196. SAMEA Canine Influenza Vaccine Sales by Application (2027-2032) & (W Units) Table 197. SAMEA Canine Influenza Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 198. SAMEA Canine Influenza Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 199. SAMEA Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Canine Influenza Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Canine Influenza Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 203. SAMEA Canine Influenza Vaccine Sales by Country (2021-2026) & (W Units) Table 204. SAMEA Canine Influenza Vaccine Sales by Country (2027-2032) & (W Units) Table 205. SAMEA Canine Influenza Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 206. SAMEA Canine Influenza Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Brazil Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Argentina Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Chile Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Colombia Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Peru Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Israel Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 214. UAE Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Turkey Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Iran Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Egypt Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Canine Influenza Vaccine Distributors List Table 221. Canine Influenza Vaccine Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Canine Influenza Vaccine Image Figure 2. Global Canine Influenza Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Influenza Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. H3N2 Vaccine Image Figure 5. H3N8 Vaccine Image Figure 6. Global Canine Influenza Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Canine Influenza Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Vaccination Clinic Image Figure 9. Pet Hospital Image Figure 10. Others Image Figure 11. Global Canine Influenza Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Canine Influenza Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Canine Influenza Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Canine Influenza Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Canine Influenza Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Canine Influenza Vaccine Sales (2021-2032) & (W Units) Figure 17. Global Canine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Canine Influenza Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Canine Influenza Vaccine Sales YoY (2021-2032) & (W Units) Figure 20. Europe Canine Influenza Vaccine Sales YoY (2021-2032) & (W Units) Figure 21. China Canine Influenza Vaccine Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Canine Influenza Vaccine Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Canine Influenza Vaccine Sales YoY (2021-2032) & (W Units) Figure 24. Global Canine Influenza Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Canine Influenza Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Canine Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Canine Influenza Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Canine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Canine Influenza Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Canine Influenza Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Canine Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Canine Influenza Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Canine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Canine Influenza Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Canine Influenza Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Canine Influenza Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Canine Influenza Vaccine Sales Share by Type (2021-2032) Figure 41. North America Canine Influenza Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Canine Influenza Vaccine Sales Share by Application (2021-2032) Figure 43. North America Canine Influenza Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Canine Influenza Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Canine Influenza Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Canine Influenza Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Canine Influenza Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Canine Influenza Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Canine Influenza Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Canine Influenza Vaccine Sales Share by Country (2021-2032) Figure 51. China Canine Influenza Vaccine Revenue Share by Type (2021-2032) Figure 52. China Canine Influenza Vaccine Sales Share by Type (2021-2032) Figure 53. China Canine Influenza Vaccine Revenue Share by Application (2021-2032) Figure 54. China Canine Influenza Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Canine Influenza Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Canine Influenza Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Canine Influenza Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Canine Influenza Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Canine Influenza Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Canine Influenza Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Canine Influenza Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Canine Influenza Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Canine Influenza Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Canine Influenza Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Canine Influenza Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Canine Influenza Vaccine Sales Share by Country (2021-2032) Figure 67. Canine Influenza Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Canine Influenza Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • H3N2 Vaccine
  • H3N8 Vaccine
Applications
  • Vaccination Clinic
  • Pet Hospital
  • Others
Companies covered
  • Bharat Biotech
  • CNBG
  • CSL Limited
  • LIAONING CHENGDA
  • Merck Animal Health
  • GSK
  • Roche
  • Novartis
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Canine Influenza Vaccine Market by Type
  3. 1.2.1 Global Canine Influenza Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 H3N2 Vaccine
  5. 1.2.3 H3N8 Vaccine
  6. 1.3 Canine Influenza Vaccine Market by Application
  7. 1.3.1 Global Canine Influenza Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Vaccination Clinic
  9. 1.3.3 Pet Hospital
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Canine Influenza Vaccine Market Dynamics
  1. 2.1 Canine Influenza Vaccine Industry Trends
  2. 2.2 Canine Influenza Vaccine Industry Drivers
  3. 2.3 Canine Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Influenza Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Canine Influenza Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Canine Influenza Vaccine Revenue by Region
  3. 3.2.1 Global Canine Influenza Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Canine Influenza Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Canine Influenza Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Canine Influenza Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Canine Influenza Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Canine Influenza Vaccine Sales by Region
  9. 3.4.1 Global Canine Influenza Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Canine Influenza Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Canine Influenza Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Canine Influenza Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Canine Influenza Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Canine Influenza Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Canine Influenza Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Canine Influenza Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Canine Influenza Vaccine Sales by Manufacturers
  6. 4.2.1 Global Canine Influenza Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Canine Influenza Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Canine Influenza Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Canine Influenza Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Canine Influenza Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Canine Influenza Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Canine Influenza Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Canine Influenza Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Canine Influenza Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Canine Influenza Vaccine Tier 1, Tier 2, and Tier 3
5 Canine Influenza Vaccine Market by Type
  1. 5.1 Global Canine Influenza Vaccine Revenue by Type
  2. 5.1.1 Global Canine Influenza Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Canine Influenza Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Canine Influenza Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Canine Influenza Vaccine Sales by Type
  6. 5.2.1 Global Canine Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Canine Influenza Vaccine Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Canine Influenza Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Canine Influenza Vaccine Price by Type
6 Canine Influenza Vaccine Market by Application
  1. 6.1 Global Canine Influenza Vaccine Revenue by Application
  2. 6.1.1 Global Canine Influenza Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Canine Influenza Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Canine Influenza Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Canine Influenza Vaccine Sales by Application
  6. 6.2.1 Global Canine Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Canine Influenza Vaccine Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Canine Influenza Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Canine Influenza Vaccine Price by Application
7 Company Profiles
  1. 7.1 Bharat Biotech
  2. 7.1.1 Bharat Biotech Company Information
  3. 7.1.2 Bharat Biotech Business Overview
  4. 7.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bharat Biotech Canine Influenza Vaccine Product Portfolio
  6. 7.1.5 Bharat Biotech Recent Developments
  7. 7.2 CNBG
  8. 7.2.1 CNBG Company Information
  9. 7.2.2 CNBG Business Overview
  10. 7.2.3 CNBG Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CNBG Canine Influenza Vaccine Product Portfolio
  12. 7.2.5 CNBG Recent Developments
  13. 7.3 CSL Limited
  14. 7.3.1 CSL Limited Company Information
  15. 7.3.2 CSL Limited Business Overview
  16. 7.3.3 CSL Limited Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL Limited Canine Influenza Vaccine Product Portfolio
  18. 7.3.5 CSL Limited Recent Developments
  19. 7.4 LIAONING CHENGDA
  20. 7.4.1 LIAONING CHENGDA Company Information
  21. 7.4.2 LIAONING CHENGDA Business Overview
  22. 7.4.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 LIAONING CHENGDA Canine Influenza Vaccine Product Portfolio
  24. 7.4.5 LIAONING CHENGDA Recent Developments
  25. 7.5 Merck Animal Health
  26. 7.5.1 Merck Animal Health Company Information
  27. 7.5.2 Merck Animal Health Business Overview
  28. 7.5.3 Merck Animal Health Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Animal Health Canine Influenza Vaccine Product Portfolio
  30. 7.5.5 Merck Animal Health Recent Developments
  31. 7.6 GSK
  32. 7.6.1 GSK Company Information
  33. 7.6.2 GSK Business Overview
  34. 7.6.3 GSK Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GSK Canine Influenza Vaccine Product Portfolio
  36. 7.6.5 GSK Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Roche Canine Influenza Vaccine Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Canine Influenza Vaccine Product Portfolio
  48. 7.8.5 Novartis Recent Developments
  49. 7.9 Zoetis
  50. 7.9.1 Zoetis Company Information
  51. 7.9.2 Zoetis Business Overview
  52. 7.9.3 Zoetis Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Canine Influenza Vaccine Product Portfolio
  54. 7.9.5 Zoetis Recent Developments
8 North America
  1. 8.1 North America Canine Influenza Vaccine Market Size by Type
  2. 8.1.1 North America Canine Influenza Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Canine Influenza Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Canine Influenza Vaccine Price by Type (2021-2032)
  5. 8.2 North America Canine Influenza Vaccine Market Size by Application
  6. 8.2.1 North America Canine Influenza Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Canine Influenza Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Canine Influenza Vaccine Price by Application (2021-2032)
  9. 8.3 North America Canine Influenza Vaccine Market Size by Country
  10. 8.3.1 North America Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Canine Influenza Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Canine Influenza Vaccine Market Size by Type
  2. 9.1.1 Europe Canine Influenza Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Canine Influenza Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Canine Influenza Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Canine Influenza Vaccine Market Size by Application
  6. 9.2.1 Europe Canine Influenza Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Canine Influenza Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Canine Influenza Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Canine Influenza Vaccine Market Size by Country
  10. 9.3.1 Europe Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Canine Influenza Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Canine Influenza Vaccine Market Size by Type
  2. 10.1.1 China Canine Influenza Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Canine Influenza Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Canine Influenza Vaccine Price by Type (2021-2032)
  5. 10.2 China Canine Influenza Vaccine Market Size by Application
  6. 10.2.1 China Canine Influenza Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Canine Influenza Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Canine Influenza Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Canine Influenza Vaccine Market Size by Type
  2. 11.1.1 Asia Canine Influenza Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Canine Influenza Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Canine Influenza Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Canine Influenza Vaccine Market Size by Application
  6. 11.2.1 Asia Canine Influenza Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Canine Influenza Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Canine Influenza Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Canine Influenza Vaccine Market Size by Country
  10. 11.3.1 Asia Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Canine Influenza Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Canine Influenza Vaccine Market Size by Type
  2. 12.1.1 SAMEA Canine Influenza Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Canine Influenza Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Canine Influenza Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Canine Influenza Vaccine Market Size by Application
  6. 12.2.1 SAMEA Canine Influenza Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Canine Influenza Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Canine Influenza Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Canine Influenza Vaccine Market Size by Country
  10. 12.3.1 SAMEA Canine Influenza Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Canine Influenza Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Canine Influenza Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Canine Influenza Vaccine Value Chain Analysis
  2. 13.1.1 Canine Influenza Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Canine Influenza Vaccine Production Mode & Process
  6. 13.2 Canine Influenza Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Canine Influenza Vaccine Distributors
  9. 13.2.3 Canine Influenza Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst